| Product Code: ETC9411039 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Pharmacogenetic Testing Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 South Korea Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 South Korea Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 South Korea Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 South Korea Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 South Korea Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 South Korea Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 South Korea Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 South Korea Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 South Korea Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about personalized medicine and its benefits in South Korea |
4.2.2 Growing adoption of pharmacogenetic testing in clinical practice |
4.2.3 Government initiatives promoting precision medicine and genetic testing |
4.3 Market Restraints |
4.3.1 Limited reimbursement policies for pharmacogenetic testing |
4.3.2 Lack of standardized guidelines for pharmacogenetic testing implementation |
4.3.3 Concerns about data privacy and security in genetic testing |
5 South Korea Pharmacogenetic Testing Market Trends |
6 South Korea Pharmacogenetic Testing Market, By Types |
6.1 South Korea Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 South Korea Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 South Korea Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 South Korea Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 South Korea Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 South Korea Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 South Korea Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 South Korea Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 South Korea Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 South Korea Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 South Korea Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 South Korea Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 South Korea Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 South Korea Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 South Korea Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 South Korea Pharmacogenetic Testing Market Export to Major Countries |
7.2 South Korea Pharmacogenetic Testing Market Imports from Major Countries |
8 South Korea Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Number of healthcare facilities offering pharmacogenetic testing services |
8.2 Percentage of healthcare professionals trained in pharmacogenetic testing |
8.3 Adoption rate of pharmacogenetic testing in different medical specialties |
8.4 Number of research studies and publications related to pharmacogenetic testing in South Korea |
8.5 Patient satisfaction and outcomes improvement after undergoing pharmacogenetic testing |
9 South Korea Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 South Korea Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 South Korea Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 South Korea Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 South Korea Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 South Korea Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 South Korea Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 South Korea Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 South Korea Pharmacogenetic Testing Market - Competitive Landscape |
10.1 South Korea Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 South Korea Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here